Back to mobile site

More on FDMT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-3.1% Growth)
- Ratings (7.5 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

4D Molecular Therapeutics Inc. (NQ:FDMT)
Delayed: 10.96 -0.42 (3.69%)
Prev. Close $11.38  
Open$11.20 
52 Wk High$ 
52 Wk Low$ 
Day High$11.43 
Day Low$10.91 
P/E N/A  
EPS$ 
Volume717,183 

Friends, Peers and Foes (?): AURA NBP (more...)

Jul 20, 2026 08:30 AM Form 8-K 4D Molecular Therapeutic For: Jul 18
Jul 20, 2026 06:51 AM H.C. Wainwright Reiterates Buy Rating on 4D Molecular Therapeutics (FDMT)
Jul 14, 2026 05:05 PM Form 4 4D Molecular Therapeutic For: Jul 09 Filed by: Kirn David
Jul 10, 2026 04:55 PM Form 144 4D Molecular Therapeutic Filed by: Kirn David
Jul 9, 2026 05:22 PM Form 144 4D Molecular Therapeutic Filed by: Kirn David
Jul 2, 2026 04:08 PM Form 4 4D Molecular Therapeutic For: Jun 30 Filed by: Bizily Scott
Jun 30, 2026 04:39 PM Form 144 4D Molecular Therapeutic Filed by: Bizily Scott
Jun 30, 2026 06:44 AM H.C. Wainwright Reiterates Buy Rating on 4D Molecular Therapeutics (FDMT)
Jun 29, 2026 08:05 AM Form 8-K 4D Molecular Therapeutic For: Jun 24
Jun 29, 2026 08:00 AM 4DMT secures $200M credit facility with Hercules Capital
View All Articles

Entities mentioned with FDMT

View All Entities